Skip to content
Open access

Clinical and genetic spectrum of dual rare genetic diseases revealed by whole-exome sequencing in 14 pediatric patients

Sep 2026 · Orphanet Journal of Rare Diseases · Vol 21 · 0 citations · 16 references
Medicine

TL;DR

WES effectively detects multiple variant types providing crucial insights for precise diagnosis, management, and genetic counseling in children with complex phenotypes, providing crucial insights for precise diagnosis, management, and genetic counseling in children with complex phenotypes.

Abstract

Dual molecular diagnoses, defined as the coexistence of pathogenic variants in two distinct disease-causing genes, challenge the traditional single-gene model of Mendelian inheritance. With the advent of whole-exome sequencing (WES), such complex genotypes are increasingly recognized. To investigate the clinical and genetic spectrum of dual rare genetic diseases in pediatric patients and to assess the diagnostic utility of WES in detecting diverse variant types. A retrospective analysis was conducted on 872 children with suspected rare genetic disorders who underwent proband or trio-based WES from January 2019 to February 2025. Variants were classified according to American College of Medical Genetics and Genomics(ACMG) guidelines. Dual diagnoses were confirmed when two independent pathogenic or likely pathogenic variants, each explaining part of the phenotype, were identified. Among 872 patients, 370 (42.4%) received a molecular diagnosis, and 14 (3.8%) were confirmed with dual molecular diagnoses. Autosomal dominant (AD) disorders were most frequent (85.7%), de novo variants represented 57.14% (8 out of 14 cases). Six patients (42.9%) harbored combinations of single nucleotide variant (SNV) and other variant types, including exon deletions, paternal uniparental disomy (UPD15). Clinically, 14.3% of cases were phenotypically distinct, while 85.7% were phenotypically overlapping. Dual molecular diagnoses occur in approximately 3.8% of molecularly diagnosed patients and frequently involve de novo dominant variants. WES effectively detects multiple variant types (including SNV, CNV, exon deletions, UPD, and mosaicism) providing crucial insights for precise diagnosis, management, and genetic counseling in children with complex phenotypes.

Read PDF

Similar papers

Open access Oct 2026

Diagnostic utility of whole exome sequencing in children with suspected genodermatoses: a single-center retrospective study

Introduction Genodermatoses are a group of monogenic inherited skin disorders characterized by marked genetic heterogeneity. Although the phenotype of many genodermatoses is readily recognizable on clinical examination, it is often insufficient to establish the precise molecular genetic etiology. Currently, the use of...

A. Kudakaeva, O. Parshina, A. Botkina et al. · 0 citations
Open access Oct 2026

Precision Medicine in Epilepsy: Diagnostic Yield by Next-Generation Sequencing and Genotype–Phenotype Findings in a Romanian Cohort

Epilepsy ranks among the most prevalent neurological disorders globally, with a substantial proportion of cases, particularly in pediatric populations, attributed to genetic etiologies. This study provides the first molecular characterization of suspected genetic epilepsy in a pediatric cohort from the Moldova region o...

L. Butnariu, Ecaterina Grigore, T. Schreiner et al. · 0 citations
Review Open access Sep 2026

Independent coexistence of diseases in neurogenetics: case reports and literature review

13 patients from 12 families with two hereditary diseases of the nervous system, verified by DNA analysis, are described and 8 gene variants are identified, 8 of which have not been previously described.

G. Rudenskaya, A. Kuchina, E. Melnik et al. · 0 citations
Open access Oct 2026

Phenotypic Complexity and Diagnostic Utility of Exome Sequencing in ASD: Real-World Insights from Colombia

Autism spectrum disorder (ASD) is a genetically heterogeneous condition; however, genomic data from Latin American populations remain limited. We investigated the molecular and phenotypic landscape of ASD in 916 Colombian patients who underwent whole-exome sequencing (WES) between 2022 and 2025. Clinical and genomic da...

Diego Alejandro Rodríguez Gutiérrez, Ronald Cardenas-Prieto, Paula Rueda-Gaitán et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.